SCHEMBL1400940

SCHEMBL1400940

CCCCCCCCC(=O)N(C)Cc1cc(-c2ccc(CCC(=O)O)cc2OCC(C)C)cs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.40
S1PR5 Q9H228 2/20 0.37
RXRA P19793 1/20 0.37
CYP3A4 P08684 3/20 0.36
CYP2C8 P10632 3/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2B6 P20813 3/20 0.36
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
FFAR4 Q5NUL3 1/20 0.35
HTR1A P08908 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2A6 P11509 2/20 0.34
CYP2E1 P05181 1/20 0.34
LTA4H P09960 1/20 0.34
TP53 P04637 1/20 0.34
MDM2 Q00987 1/20 0.34
FOS P01100 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67070 0.92 RXRA (0.44) S1PR1S1PR5RXRACYP3A4CYP2C8
SCHEMBL69550 0.92 CYP3A4 (0.37) CYP3A4CYP2C8CYP2C9CYP2B6CYP2C19
SCHEMBL68946 0.89 PTGER1 (0.47) RXRAFFAR4PTGER1PTGER4PTGER3
SCHEMBL1400699 0.89 ALOX15 (0.36) CYP2C19CYP2D6PTGER1PTGER4PTGER3
SCHEMBL67082 0.85 PPARG (0.42) S1PR1S1PR5RXRATHRATHRB
SCHEMBL69838 0.84 AKR1C3 (0.44) THRBHTR1A
SCHEMBL69837 0.84 AKR1C3 (0.44) THRBHTR1A
SCHEMBL70089 0.83 CYP1A2 (0.38) RXRACYP3A4CYP2C8CYP2C9CYP2B6
SCHEMBL1400944 0.82 S1PR1 (0.38) S1PR1S1PR5RXRACYP3A4CYP2C8
SCHEMBL68745 0.81 FFAR1 (0.42) RXRAFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814871-B1 COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RES & DEV (FR) 2011-03-02 EP claimed